Maximilian Reinhardt
Overview
Explore the profile of Maximilian Reinhardt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Renkhold L, Pereira M, Loser K, Metze D, Baeumer D, Melzer N, et al.
Acta Derm Venereol
. 2024 Nov;
104:adv40737.
PMID: 39565228
The occurrence of pruritus in psoriasis was previously underestimated but is a significant burden. Secukinumab (SEC), a monoclonal anti-interleukin-17A antibody, efficiently controls signs of psoriasis, but the effect on pruritus...
2.
Passeron T, Reinhardt M, Ehst B, Weiss J, Sluzevich J, Sticherling M, et al.
Br J Dermatol
. 2024 May;
191(5):680-690.
PMID: 38735684
Background: Patients with lichen planus (LP) refractory to available therapies often experience a high disease burden, representing a population with a clear unmet need for new treatments. Objectives: To evaluate...
3.
Schruf E, Biermann M, Jacob J, Hackl D, Reinhardt M, Hertl M, et al.
J Dtsch Dermatol Ges
. 2022 Aug;
20(8):1101-1111.
PMID: 35971586
Hintergrund Und Ziele: Lichen planus (LP) ist eine chronisch entzündliche Hauterkrankung, die eine große Belastung für die betroffenen Patienten darstellt. Es liegen jedoch nur wenige Daten zu dieser Erkrankung vor....
4.
Schruf E, Biermann M, Jacob J, Hackl D, Reinhardt M, Hertl M, et al.
J Dtsch Dermatol Ges
. 2022 Aug;
20(8):1101-1110.
PMID: 35913102
Background And Objectives: Lichen planus (LP) is a chronic inflammatory skin disease and is a major burden for affected patients. However, data on this condition are scarce. This study aims...
5.
Abid A, Reinhardt M, Boudjemia N, Pelimanni E, Milosavljevic A, Saak C, et al.
RSC Adv
. 2022 Apr;
11(4):2103-2111.
PMID: 35424180
Ca- and Cl-containing nanoparticles are common in atmosphere, originating for example from desert dust and sea water. The properties and effects on atmospheric processes of these aerosol particles depend on...
6.
Sigurgeirsson B, Browning J, Tyring S, Szepietowski J, Rivera-Diaz R, Effendy I, et al.
Dermatol Ther
. 2021 Dec;
35(3):e15285.
PMID: 34954841
Convenient administration is an important factor for treatment adherence in patients with psoriasis. MATURE study reports the efficacy, safety, tolerability, and pharmacokinetics (PKs) of secukinumab 300 mg 2 ml autoinjector...
7.
Pinter A, Schwarz P, Gerdes S, Simon J, Saalbach A, Rush J, et al.
Nutrients
. 2021 Sep;
13(9).
PMID: 34578893
Inflammatory diseases including psoriasis are associated with metabolic and cardiovascular comorbidities, including obesity and metabolic syndrome. Obesity is associated with greater psoriasis disease severity and reduced response to treatment. Therefore,...
8.
Pilz A, Zink A, Schielein M, Hell K, Romer K, Hillmann E, et al.
J Dtsch Dermatol Ges
. 2021 Jul;
19(7):1003-1012.
PMID: 34288484
Hintergrund Und Ziele: Durch die Entwicklung neuer anti-psoriatischer Medikamente und verbesserte Strukturen zu deren flächendeckender Einführung hat sich die medizinische Versorgung von Psoriasis-Patienten deutlich verbessert. In dieser Studie haben wir...
9.
Pilz A, Zink A, Schielein M, Hell K, Romer K, Hillmann E, et al.
J Dtsch Dermatol Ges
. 2021 May;
19(7):1003-1011.
PMID: 33955676
Background And Objectives: Due to the development of new anti-psoriatic drugs in combination with improved structures for implementation throughout Germany, the medical care of psoriasis patients has markedly improved. In...
10.
Patients with Chronic Urticaria Remain Largely Undertreated: Results from the DERMLINE Online Survey
Wagner N, Zink A, Hell K, Reinhardt M, Romer K, Hillmann E, et al.
Dermatol Ther (Heidelb)
. 2021 May;
11(3):1027-1039.
PMID: 33945120
Introduction: Chronic urticaria (CU) is an unpredictable disease, with high disease burden and a significant negative impact on quality of life, especially in patients of working age. Many patients are...